Clearwater Paper Reports Second Quarter 2017 Results

The company reported net sales of $429.7 million for the second quarter of 2017, down 1.6% compared to net sales of $436.7 million for the second quarter of 2016. Net earnings determined in accordance with generally accepted accounting principles, or GAAP, for the second quarter of 2017 were $8.0 million, or $0.48 per diluted share, compared to net earnings of $20.9 million, or $1.21 per diluted share, for the second quarter of 2016.

The decrease in net earnings was due primarily to a planned bi-annual major maintenance outage at the Company’s Arkansas mill in the second quarter of 2017 and higher input costs for energy, pulp, chemicals, and packaging supplies. Excluding certain non-core items identified in the attached Reconciliation of Non-GAAP Financial Measures, second quarter 2017 adjusted net earnings were $7.9 million, or $0.48 per diluted share, compared to second quarter 2016 adjusted net earnings of $23.5 million, or $1.37 per diluted share.

Earnings before interest, taxes, depreciation and amortization, or EBITDA, was $45.7 million for the second quarter of 2017 compared to $62.2 million for the second quarter of 2016. Adjusted EBITDA for the quarter was $45.0 million, down 32.1% compared to second quarter 2016 Adjusted EBITDA of $66.3 million. The $21.3 million decrease in adjusted EBITDA was primarily a result of the same major maintenance and higher input costs affecting GAAP net earnings in the second quarter of 2017.

“We achieved solid second quarter results that were in line with our quarterly outlook,” said Linda K. Massman, president and chief executive officer. “The positive impacts to the quarter included higher prices and a stronger sales mix for paperboard, which were offset by higher external pulp pricing and lower consumer product shipment volumes, as parent rolls were used to build needed inventory.

I am also pleased to share that our previously disclosed strategic projects remain on time and within budget, and we continue to believe this will position us to more efficiently partner with and meet the needs of our customers in the future,” said Massman.

read more/source: http://ir.clearwaterpaper.com/releasedetail.cfm?ReleaseID=1035720

Related Posts

Norske Skog Bruck announces successful commercial deliveries of containerboard

Norske Skog Bruck announces successful commercial orders of the containerboard grades Testliner 3 and Fluting. This represents the introduction of 210,000 tonnes of competitive containerboard capacity to meet the growing demand for renewable and re-usable packaging. The production is based 100% on recycled fibre and will use steam from the waste-to-energy plant, which opened in April 2022. Norske Skog Bruck is now ramping up production and expects full utilisation of 95% in the second half of 2025. The successful commercial orders of Strato Testliner 3 and Fluting mark a new era for Norske Skog and strengthen the company's asset base and cash flow generation for decades ahead.

O-I Reports First Quarter 2018 Results

Highlights: • For the first quarter 2018, the Company recorded earnings from continuing operations of $0.59 per share (diluted). This was on the upper end of management guidance of $0.55 to $0.60 per share. • Net sales were $1.7 billion, an increase of nearly 8 percent compared to the prior year, due to higher prices and favorable currency translation. Total glass container shipments in the first quarter of 2018 were comparable to the prior year quarter, with low-single-digit gains reported in the Americas. • Earnings from continuing operations before income taxes were $135 million, compared with $73 million in the prior year, driven by solid operational performance and non-recurrence of certain expenses in the prior year. Click Read More below for additional information.

Virox Technologies Inc. and Diversey, Inc. Sign Deal to Bring The Next Advancement in Sustainable Disinfection to Healthcare Professionals

Virox Technologies Inc., a leading innovator of patented, sustainable disinfectant chemistries, today announces that it has finalized multi-year licensing and supply agreements with Diversey, A Solenis Company, to bring its latest patented disinfectant technology, Citr-IQTM, to the healthcare sector and others. Diversey is a leading provider of hygiene, infection prevention and cleaning products, and technology, and will add multiple disinfectant products, powered by Virox’s Citr-IQ, to its lineup of professional offerings. Under the terms of the agreements, Virox will receive undisclosed license fees and royalties for the use of the formulas covered under the patented Citr-IQ disinfectant platform, as well as manufacture products containing the Citr-IQ formulas for Diversey’s North American markets. These Citr-IQ products will be produced in Virox’s LEED® Gold Certified manufacturing facility in Oakville, Ontario, Canada. Diversey has previously licensed chemical disinfectant technology from Virox with the patented Accelerated Hydrogen Peroxide® (AHP®) platform, which Diversey fully acquired from Virox in 2019. AHP was created by Virox in 1998, and successfully transformed disinfection with a safe, effective, and sustainable patented chemistry. AHP is used across the globe in human and animal health sectors and is the active ingredient in multiple brands, including Diversey’s Oxivir® and Accel® infection prevention platforms.
Back To Top
×Close search
Search